What are the major opportunities in the Polivy market? What are the strategies for the Polivy market?

For detailed insights on the major opportunities and strategies in the Polivy market, Read More

How does the Polivy market relate to the overall economy and other similar markets?

For detailed insights on Polivy's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Polivy industry?

For detailed insights on the mergers and acquisitions in the Polivy industry, Read More

What are the key dynamics influencing the Polivy market growth? SWOT analysis of the Polivy market.

For detailed insights on the key dynamics influencing the Polivy market growth and SWOT analysis of the Polivy industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Polivy Global Market Report 2025

Name: Polivy Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Previously Untreated Diffuse Large B-Cell Lymphoma, Relapsed Or Refractory Diffuse Large B-Cell Lymphoma), By Dosage Form (Injectable Solution), By Distribution Channel (Direct Sales, Pharmaceutical Wholesalers, Online Pharmacies)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Polivy Market?

Polivy (polatuzumab vedotin) is an antibody-drug conjugate used for the treatment of diffuse large B-cell lymphoma, which is a type of non-Hodgkin lymphoma. It is specifically indicated for adult patients with relapsed or refractory diffuse large B-cell lymphoma after they have undergone at least two prior therapies. Additionally, it can be used as a first-line treatment in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone for patients with moderate- to high-risk diffuse large B-cell lymphoma.

The main indications of polivy are previously untreated diffuse large b-cell lymphoma, relapsed or refractory diffuse large b-cell lymphoma. Previously untreated diffuse large B-cell lymphoma is a form of cancer affecting white blood cells that have not received any prior treatment. It is typically aggressive and requires prompt medical intervention. Polivy is used as part of combination therapy to address this condition effectively. It is dose in the form of injectable solutions and distributed through various channels such as direct sales, pharmaceutical wholesalers, and online Pharmacies.

Polivy Market Size and growth rate 2025 to 2029: Graph

What Is The Polivy Market Size 2025 And Growth Rate?

The polivy market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rising prevalence of diffuse large B-cell lymphoma, growth in the number of clinical trials, growing healthcare expenditure in oncology research, increasing diagnosis rates, and rising availability of targeted therapies.

What Is The Polivy Market Growth Forecast?

The polivy market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising incidence of cancer, increasing demand for personalized medicine, growing patient populations, improving health insurance coverage, and expanding use of digital health tools. Major trends in the forecast period include advancement in targeted drug delivery systems, development of subcutaneous formulations, advancements in intravenous infusion methods, development of long-acting formulations, and integration of polivy in early-stage lymphoma treatments.

Book your 30 minutes free consultation with our research experts

How Is The Polivy Market Segmented?

The polivy market covered in this report is segmented –

1) By Indication: Previously Untreated Diffuse Large B-Cell Lymphoma, Relapsed Or Refractory Diffuse Large B-Cell Lymphoma

2) By Dosage Form: Injectable Solution

3) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Online Pharmacies

What Is Driving The Polivy Market? Growing Incidence Of Diffuse Large B-Cell Lymphoma Boosts Demand For Polivy

The increasing incidence of diffuse large B-cell lymphoma is expected to propel the growth of the polivy market going forward. Diffuse large B-cell lymphoma (DLBCL), the most prevalent type of non-hodgkin lymphoma (NHL), is classified as a highly aggressive blood cancer that originates from B-lymphocytes, which are white blood cells essential for the immune system's function of producing antibodies to combat infections. The increasing incidence of diffuse large B-cell lymphoma can be attributed to several factors, including an aging population, rising rates of immunosuppression due to conditions such as HIV/AIDS and organ transplants, and environmental exposures that contribute to the disease's etiology. Polivy is used in combination with chemotherapy to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in patients who have received prior treatments. For instance, in July 2024, according to a report published by the Royal College of Pathologists, a UK-based professional membership organization, each year in the UK, approximately 5,500 individuals are diagnosed with diffuse large B-cell lymphoma (DLBCL), which is a highly aggressive form of non-Hodgkin lymphoma. About 30% of these patients will experience refractory disease or relapse shortly after their initial treatment. Therefore, the increasing incidence of diffuse large B-cell lymphoma is driving the growth of the polivy market.

What Is Driving The Polivy Market? Rising Healthcare Spending To Accelerate Polivy Adoption

Rising healthcare spending is expected to propel the growth of the polivy market going forward. Healthcare spending refers to the total financial resources allocated for medical services and goods, including hospital care, outpatient services, pharmaceuticals, and preventive care, funded by government budgets, private insurance, and out-of-pocket payments to promote and maintain health. Rising healthcare spending is primarily driven by factors such as an increasing global population, greater demand for healthcare services, advancements in medical technology, the prevalence of chronic diseases, and rising prices for healthcare products and services. Rising healthcare spending benefits polivy by supporting its use in treating moderate-to-high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL), as increased investment in healthcare enhances market access and adoption of innovative cancer therapies. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, in 2023, it is estimated that approximately $292 billion was allocated to current healthcare in the UK, based on nominal prices. This represents a nominal increase of 5.6% in total healthcare expenditure compared to the previous year. Therefore, the rising healthcare spending is driving the growth of the polivy market.

What Is Driving The Polivy Market? Surge In Oncology Procedures To Boost Polivy Adoption

The rise in the number of oncology procedures is expected to fuel the growth of the polivy market going forward. Oncology procedures are medical interventions, tests, and treatments used to diagnose, manage, and treat cancer, which may include surgery, chemotherapy, radiation therapy, and other specialized techniques, depending on the type and stage of cancer. The rise in the number of oncology procedures is primarily driven by an increasing incidence of cancer, improved survival rates leading to a growing population of cancer survivors requiring ongoing care, and the complexity of modern cancer treatments necessitating more frequent medical interventions. Polivy is used in oncology to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) by targeting CD79b on cancerous B-cells and delivering chemotherapy directly to them. For instance, in January 2023, according to a report published by NHS England, a UK-based government agency, more than 320,000 individuals received cancer treatment in the past year (November 2021 to October 2022), marking the highest number ever recorded, an increase of over 8,000 compared to the same period before the pandemic. Therefore, the rise in the number of oncology procedures is driving the growth of the polivy market.

Who Are The Major Players In The Global Polivy Market?

Major companies operating in the polivy market include F. Hoffmann-La Roche Ltd (Genentech Inc.)

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Polivy Market

North America was the largest region in the polivy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polivy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the polivy market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Polivy Market?

The polivy market consists of sales of polivy (polatuzumab vedotin) injections in 30 mg and 140 mg vials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Polivy Industry?

The polivy market research report is one of a series of new reports from The Business Research Company that provides polivy market statistics, including the polivy industry's global market size, regional shares, competitors with a polivy market share, detailed polivy market segments, market trends and opportunities, and any further data you may need to thrive in the polivy industry. This polivy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Polivy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Indication: Previously Untreated Diffuse Large B-Cell Lymphoma, Relapsed Or Refractory Diffuse Large B-Cell Lymphoma 2) By Dosage Form: Injectable Solution 3) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Online Pharmacies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche Ltd (Genentech Inc.)
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Polivy Market Characteristics

3. Polivy Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Polivy Market Trends And Strategies

5. Polivy Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Polivy Growth Analysis And Strategic Analysis Framework

6.1. Global Polivy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Polivy Market Growth Rate Analysis

6.4. Global Polivy Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Polivy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Polivy Total Addressable Market (TAM)

7. Global Polivy Pricing Analysis & Forecasts

8. Polivy Market Segmentation

8.1. Global Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Previously Untreated Diffuse Large B-Cell Lymphoma

Relapsed Or Refractory Diffuse Large B-Cell Lymphoma

8.2. Global Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Injectable Solution

8.3. Global Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Direct Sales

Pharmaceutical Wholesalers

Online Pharmacies

9. Global Polivy Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Polivy Market Regional And Country Analysis

10.1. Global Polivy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Polivy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Polivy Market

11.1. Asia-Pacific Polivy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Polivy Market

12.1. China Polivy Market Overview

12.2. China Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Polivy Market

13.1. India Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Polivy Market

14.1. Japan Polivy Market Overview

14.2. Japan Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Polivy Market

15.1. Australia Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Polivy Market

16.1. South Korea Polivy Market Overview

16.2. South Korea Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Polivy Market

17.1. Western Europe Polivy Market Overview

17.2. Western Europe Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Polivy Market

18.1. UK Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Polivy Market

19.1. Germany Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Polivy Market

20.1. France Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Polivy Market

21.1. Eastern Europe Polivy Market Overview

21.2. Eastern Europe Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Polivy Market

22.1. North America Polivy Market Overview

22.2. North America Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Polivy Market

23.1. USA Polivy Market Overview

23.2. USA Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Polivy Market

24.1. Canada Polivy Market Overview

24.2. Canada Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Polivy Market

25.1. South America Polivy Market Overview

25.2. South America Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Polivy Market

26.1. Middle East Polivy Market Overview

26.2. Middle East Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Polivy Market

27.1. Africa Polivy Market Overview

27.2. Africa Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Polivy Market Competitive Landscape And Company Profiles

28.1. Polivy Market Competitive Landscape

28.2. Polivy Market Company Profiles

28.2.1. F. Hoffmann-La Roche Ltd (Genentech Inc.) Overview, Products and Services, Strategy and Financial Analysis

29. Global Polivy Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Polivy Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Polivy Market

32. Recent Developments In The Polivy Market

33. Polivy Market High Potential Countries, Segments and Strategies

33.1 Polivy Market In 2029 - Countries Offering Most New Opportunities

33.2 Polivy Market In 2029 - Segments Offering Most New Opportunities

33.3 Polivy Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Polivy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Polivy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: F. Hoffmann-La Roche Ltd (Genentech Inc.) Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Polivy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Polivy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Polivy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: F. Hoffmann-La Roche Ltd (Genentech Inc.) Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others...

Genito-Urinary Drugs Global Market Report 2022 – By Type (Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overact...

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Frequently Asked Questions

What is the definition of the Polivy market?

How will the Polivy market drivers and restraints affect the market dynamics? What forces will shape the Polivy industry going forward?

The Polivy market major growth driver - Growing Incidence Of Diffuse Large B-Cell Lymphoma Boosts Demand For Polivy. For further insights on the Polivy market, request a sample here

What is the forecast market size or the forecast market value of the Polivy market?

The Polivy market size has grown strongly in recent years. The polivy market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rising prevalence of diffuse large B-cell lymphoma, growth in the number of clinical trials, growing healthcare expenditure in oncology research, increasing diagnosis rates, and rising availability of targeted therapies. The polivy market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising incidence of cancer, increasing demand for personalized medicine, growing patient populations, improving health insurance coverage, and expanding use of digital health tools. Major trends in the forecast period include advancement in targeted drug delivery systems, development of subcutaneous formulations, advancements in intravenous infusion methods, development of long-acting formulations, and integration of polivy in early-stage lymphoma treatments. For further insights on the Polivy market, request a sample here

How is the Polivy market segmented?

The polivy market covered in this report is segmented –
1) By Indication: Previously Untreated Diffuse Large B-Cell Lymphoma, Relapsed Or Refractory Diffuse Large B-Cell Lymphoma
2) By Dosage Form: Injectable Solution
3) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Online Pharmacies For further insights on the Polivy market, request a sample here

Which region has the largest share of the Polivy market? What are the other regions covered in the report?

Who are the major players in the Polivy market?

Major companies operating in the polivy market include F. Hoffmann-La Roche Ltd (Genentech Inc.) . For further insights on the Polivy market, request a sample here.

What are the key trends in the Polivy market?

Major trends in the Polivy market include . For further insights on the Polivy market, request a sample here.